These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1664985)

  • 21. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
    Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
    Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epstein-Barr virus and post-transplantation lymphoproliferations].
    Leblond V
    Ann Med Interne (Paris); 1997; 148(5):376-8. PubMed ID: 9538412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
    Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
    Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
    [No Abstract]   [Full Text] [Related]  

  • 24. X-linked lymphoproliferative syndrome provides clues to the pathogenesis of Epstein-Barr virus-induced lymphomagenesis.
    Purtilo DT; Yasuda N; Grierson HL; Okano M; Brichacek B; Davis J
    Princess Takamatsu Symp; 1987; 18():149-58. PubMed ID: 2852188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Persistent infection by Epstein-Barr virus].
    Etzioni A; Erde P
    Harefuah; 1987 Aug; 113(3-4):72-4. PubMed ID: 2826317
    [No Abstract]   [Full Text] [Related]  

  • 26. [X-linked lymphoproliferative (XLP) syndrome (Duncan disease)].
    Nakamura Y
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):158-60. PubMed ID: 10201165
    [No Abstract]   [Full Text] [Related]  

  • 27. Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.
    Nalesnik MA; Starzl TE
    Transplant Sci; 1994 Sep; 4(1):61-79. PubMed ID: 7804700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epstein-Barr virus infection: immunology and immunopathology].
    Geelen SP; Kuis W; Roord JJ; Stoop JW; Kapsenberg JG
    Ned Tijdschr Geneeskd; 1986 Jan; 130(2):63-7. PubMed ID: 3005887
    [No Abstract]   [Full Text] [Related]  

  • 29. The Epstein-Barr virus and the distinction between benign and malignant lymphoproliferative processes.
    Yarbro JW
    Semin Oncol; 1993 Dec; 20(6):658-61. PubMed ID: 8296202
    [No Abstract]   [Full Text] [Related]  

  • 30. Epstein-Barr virus infections in children.
    Sumaya CV
    Curr Probl Pediatr; 1987 Dec; 17(12):677-745. PubMed ID: 2827962
    [No Abstract]   [Full Text] [Related]  

  • 31. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
    Klein G; Purtilo D
    Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974
    [No Abstract]   [Full Text] [Related]  

  • 32. Follicular lymphoma in a X-linked lymphoproliferative syndrome carrier female.
    Woon ST; Ameratunga R; Croxson M; Taylor G; Neas K; Edkins E; Browett P; Gane E; Munn S
    Scand J Immunol; 2008 Aug; 68(2):153-8. PubMed ID: 18702745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential cellular susceptibility to Epstein-Barr virus infection in a patient with X-linked lymphoproliferative disease.
    Okano M; Thiele GM; Gross TG; Davis JR; Purtilo DT
    J Med Virol; 1990 Sep; 32(1):47-52. PubMed ID: 2173737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease.
    Hügle B; Astigarraga I; Henter JI; Porwit-MacDonald A; Meindl A; Schuster V
    Eur J Pediatr; 2007 Jun; 166(6):589-93. PubMed ID: 17058098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent aspects of Epstein-Barr virus infections].
    Hasler F
    Schweiz Med Wochenschr; 1984 Apr; 114(15):520-3. PubMed ID: 6328644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methods of detection of new families with X-linked lymphoproliferative disease.
    Purtilo DT; Grierson HL
    Cancer Genet Cytogenet; 1991 Feb; 51(2):143-53. PubMed ID: 1847089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Some aspects of the biologic behavior of Epstein-Barr virus.
    Miller G
    Adv Pathobiol; 1976; (5):25-41. PubMed ID: 220856
    [No Abstract]   [Full Text] [Related]  

  • 38. Epstein-Barr virus and the X-linked lymphoproliferative syndrome.
    Sullivan JL
    Adv Pediatr; 1983; 30():365-99. PubMed ID: 6324556
    [No Abstract]   [Full Text] [Related]  

  • 39. X-linked lymphoproliferative disease: a karyotype analysis.
    Harris A; Docherty Z
    Cytogenet Cell Genet; 1988; 47(1-2):92-4. PubMed ID: 2833379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute lymphoblastic leukemia in the context of a disorder resembling X-linked lymphoproliferative (XLP) syndrome.
    Risitano AM; Camera A; Chiurazzi F; Rossi M; D'Arco AM; Rotoli B
    Haematologica; 2002 Aug; 87(8):ELT36. PubMed ID: 12161381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.